Furthermore, T cells express inhibitory checkpoint receptors, such as programed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), which are activated by ligands expressed on pro-tumor immune cells (27). The gene discussed is CTLA4; the disease is neoplasm.